Business of regenerative medicine: preservation and the supply chain


In the third part of RegMedNet’s expert panel on the business of regenerative medicine, learn more about the challenges of designing suitable preservation processes and integrating these into a supply chain. Plus, the panelists share their predictions for the future of regenerative medicine.

Chaired by Michael May, CCRM, this panel discussion focuses on the key business challenges within regenerative medicine. Joining Michael were four leading voices in regenerative medicine and cell therapy, from research to manufacture: Robert Preti (Hitachi Chemical Advanced Therapeutics Solutions, LLC), Robert Jones (Fisher Bioservices), Carolyn Yeago (Georgia Institute of Technology) and Qasim Rafiq (UCL).

The panel discussion took place in May 2018.

Learn more on RegMedNet’s website.

All other pages contact

For more information, please contact us.

Subscribe to our mailing list to receive CCRM’s monthly newsletter.


You have Successfully Subscribed!